BR9604938A - Vírus recombinante deficiente utilização deste vírus composição farmacêutica e célula de mamífero - Google Patents
Vírus recombinante deficiente utilização deste vírus composição farmacêutica e célula de mamíferoInfo
- Publication number
- BR9604938A BR9604938A BR9604938A BR9604938A BR9604938A BR 9604938 A BR9604938 A BR 9604938A BR 9604938 A BR9604938 A BR 9604938A BR 9604938 A BR9604938 A BR 9604938A BR 9604938 A BR9604938 A BR 9604938A
- Authority
- BR
- Brazil
- Prior art keywords
- virus
- pharmaceutical composition
- mammalian cell
- recombinant virus
- deficient use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9504558A FR2732978B1 (fr) | 1995-04-14 | 1995-04-14 | Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes |
PCT/FR1996/000560 WO1996032489A1 (fr) | 1995-04-14 | 1996-04-12 | Vecteur viral recombinant inductible par le glucose |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9604938A true BR9604938A (pt) | 1998-06-09 |
Family
ID=9478162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9604938A BR9604938A (pt) | 1995-04-14 | 1996-04-12 | Vírus recombinante deficiente utilização deste vírus composição farmacêutica e célula de mamífero |
Country Status (14)
Country | Link |
---|---|
US (1) | US6309878B1 (pt) |
EP (1) | EP0821741A1 (pt) |
JP (1) | JPH11503608A (pt) |
KR (1) | KR19980703843A (pt) |
AU (1) | AU715377B2 (pt) |
BR (1) | BR9604938A (pt) |
CA (1) | CA2215987A1 (pt) |
CZ (1) | CZ292564B6 (pt) |
FR (1) | FR2732978B1 (pt) |
HU (1) | HUP9802587A3 (pt) |
MX (1) | MX9707910A (pt) |
NO (1) | NO974726L (pt) |
SK (1) | SK137797A3 (pt) |
WO (1) | WO1996032489A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5257198A (en) * | 1996-11-15 | 1998-06-03 | Millennium Pharmaceuticals, Inc. | Compositions and methods for treating type ii diabetes involving hnf-4 |
US6537806B1 (en) * | 1998-06-02 | 2003-03-25 | University Of Washington | Compositions and methods for treating diabetes |
AU777988B2 (en) * | 1999-02-19 | 2004-11-11 | Engene, Inc. | Peroral gene therapy of diabetes and obesity |
EP1889914A1 (en) * | 1999-02-19 | 2008-02-20 | Engene, Inc. | Compositions for gene therapy of diabetes |
JP3406244B2 (ja) | 1999-04-30 | 2003-05-12 | 伊藤ハム株式会社 | 新規な融合蛋白質からの組み換えインスリンの製造方法 |
HUP0201427A2 (en) | 1999-05-27 | 2002-08-28 | Ibm | Disk unit |
WO2002089855A1 (en) * | 2001-04-27 | 2002-11-14 | Auckland Uniservices Limited | Peroral transduction of hepatocytes in the treatment of disease |
DE102005024884A1 (de) * | 2005-05-31 | 2006-12-07 | Linde Ag | Arbeitsmaschine, insbesondere Flurförderzeug |
EP1890708A4 (en) * | 2005-06-01 | 2009-07-15 | Biotec Inst For Internat | GLUCOSE INDUCIBLE INSULIN EXPRESSION AND METHODS OF TREATING DIABETES |
ES2325711B1 (es) * | 2007-04-17 | 2010-06-17 | Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (Ciemat) | Vectores de expresion que comprenden el promotor del gen pklr humano y su uso para la elaboracion de composiciones farmaceuticas destinadas a terapia genica somatica con expresion especifica en celulas eritroides. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0588914A1 (en) * | 1991-05-29 | 1994-03-30 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Eukaryotic expression vectors with regulation of rna processing |
EP0648271B1 (en) * | 1991-08-20 | 2003-04-16 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Adenovirus mediated transfer of genes to the gastrointestinal tract |
GB9305759D0 (en) * | 1993-03-19 | 1993-05-05 | Medical Research Council And T | Hiv therapy method and agents |
WO1995000644A1 (en) * | 1993-06-28 | 1995-01-05 | Board Of Regents, The University Of Texas System | Vectors for genetically engineered cells that produce insulin in response to glucose |
-
1995
- 1995-04-14 FR FR9504558A patent/FR2732978B1/fr not_active Expired - Fee Related
-
1996
- 1996-04-12 AU AU56523/96A patent/AU715377B2/en not_active Ceased
- 1996-04-12 US US08/945,140 patent/US6309878B1/en not_active Expired - Fee Related
- 1996-04-12 HU HU9802587A patent/HUP9802587A3/hu unknown
- 1996-04-12 CA CA002215987A patent/CA2215987A1/fr not_active Abandoned
- 1996-04-12 KR KR1019970707243A patent/KR19980703843A/ko not_active Application Discontinuation
- 1996-04-12 JP JP8530778A patent/JPH11503608A/ja not_active Withdrawn
- 1996-04-12 MX MX9707910A patent/MX9707910A/es not_active IP Right Cessation
- 1996-04-12 CZ CZ19973251A patent/CZ292564B6/cs not_active IP Right Cessation
- 1996-04-12 WO PCT/FR1996/000560 patent/WO1996032489A1/fr not_active Application Discontinuation
- 1996-04-12 BR BR9604938A patent/BR9604938A/pt not_active Application Discontinuation
- 1996-04-12 SK SK1377-97A patent/SK137797A3/sk unknown
- 1996-04-12 EP EP96913579A patent/EP0821741A1/fr not_active Withdrawn
-
1997
- 1997-10-13 NO NO974726A patent/NO974726L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1996032489A1 (fr) | 1996-10-17 |
HUP9802587A3 (en) | 1999-12-28 |
KR19980703843A (ko) | 1998-12-05 |
CZ325197A3 (cs) | 1998-01-14 |
HUP9802587A2 (hu) | 1999-02-01 |
FR2732978A1 (fr) | 1996-10-18 |
EP0821741A1 (fr) | 1998-02-04 |
MX9707910A (es) | 1997-11-29 |
AU715377B2 (en) | 2000-02-03 |
JPH11503608A (ja) | 1999-03-30 |
NO974726D0 (no) | 1997-10-13 |
US6309878B1 (en) | 2001-10-30 |
NO974726L (no) | 1997-10-13 |
CZ292564B6 (cs) | 2003-10-15 |
CA2215987A1 (fr) | 1996-10-17 |
SK137797A3 (en) | 1998-05-06 |
AU5652396A (en) | 1996-10-30 |
FR2732978B1 (fr) | 1997-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9607317A (pt) | Peptídios e composição farmacêutica | |
BR9607318A (pt) | Peptidos e composição farmacêutica | |
IL122347A0 (en) | Recombinant adenovirus and adeno-associated virus cell lines methods of production and pharmaceutical compositions containing the same | |
FI972657A0 (fi) | Proteiinien ja peptidien aerosoliformuloinnit | |
BR1100824A (pt) | Composto e composição farmacêutica | |
IT1230118B (it) | Idrosoli di sostanze farmacologicamente attive e composizioni farmaceutiche che li contengono | |
ID28270A (id) | Komposisi dan formulasi peptida dan penggunaannya | |
DE69836424D1 (de) | Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin | |
PT907364E (pt) | Composicao farmaceutica de libertacao sustida | |
HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
DE69726007D1 (de) | Prodrogs und analoga von camptothecin und deren verwendung als arzneimittel | |
DE69522188D1 (de) | Verwendung von Substanz P Antagonist im pharmazeutischer Zusammensetzung | |
IT1291366B1 (it) | Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale | |
BR9604938A (pt) | Vírus recombinante deficiente utilização deste vírus composição farmacêutica e célula de mamífero | |
DE69520475D1 (de) | Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen | |
IL113484A0 (en) | Viral proteins pharmaceutical compositions containing them their preparation and use | |
BR9507451A (pt) | Composição farmacêutica uso de uma quantidade de (i) um antígeno padronizado em conjunto com uma quantidade de (ii) um polipeptídeo e produto contendo uma quantidade de (i) um antígeno padronizado em conjunto com uma quantidade de (ii) um polipeptídeo | |
BR9607757A (pt) | Vírus recombinante defectivo adenovírus utilização de um vírus e composição farmacêutica | |
IL109664A0 (en) | Peptides of human influenza virus for use in human t cell response inducing compositions | |
PT1222921E (pt) | Composicoes farmaceuticas de tizoxanida e nitazoxanida | |
EE200000694A (et) | Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon | |
BR9307182A (pt) | Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas | |
ATE179861T1 (de) | Zur acroleinfreisetzung befähigte zusammensetzung und deren verwendung | |
BR9507063A (pt) | Peptídeo derivado de substituição de peptídeo e composição farmacêuticas | |
BR9605220A (pt) | Gonadotropinas e composiçao farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |